Evidence map›Paper›PMID 29976874›Full record

ArticleDiagnostics (Basel, Switzerland)2018

Utility of Two-Dimensional Difference Gel Electrophoresis in Diagnosis of Multiple Sclerosis.

Michael Auer, Harald Hegen, Dagmar Rudzki, Georg Golderer, Florian Deisenhammer

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michael AuerDepartment of Neurology, Medical University of Innsbruck, Innrain 66, 6020 Innsbruck, Austria. michael.auer@i-med.ac.at.
Harald HegenDepartment of Neurology, Medical University of Innsbruck, Innrain 66, 6020 Innsbruck, Austria. harald.hegen@i-med.ac.at.
Dagmar RudzkiDepartment of Neurology, Medical University of Innsbruck, Innrain 66, 6020 Innsbruck, Austria. dagmar.rudzki@tirol-kliniken.at.
Georg GoldererDivision of Biological Chemistry, Medical University of Innsbruck, Innrain 80-83, 6020 Innsbruck, Austria. georg.golderer@i-med.ac.at.
Florian DeisenhammerDepartment of Neurology, Medical University of Innsbruck, Innrain 66, 6020 Innsbruck, Austria. florian.deisenhammer@tirol-kliniken.at.
Universität Innsbruck · ATInnsbruck Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-dimensional difference gel electrophoresis (2D-DIGE) has been used for identification of possible biomarkers in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients. However, in different studies inconsistent results have been obtained. We wanted to analyze the diagnostic value of 2D-DIGE in early MS patients by comparing protein patterns between single and pooled samples of MS patients and controls. CSF samples of 20 MS patients and 10 control subjects were processed with 2D-DIGE. The so obtained protein patterns were analyzed with DeCyder 6.5 software, whereby we described variation of patterns presented in one gel as well as between different gels. Even when running single samples of patients of the same group in one gel, variation of protein patterns was high. The number of identified spots with different protein level varied between 4 and 30, depending on which sample batches were compared. We did not find a consistent pattern throughout all possible batch combinations. The inter-individual variation of protein expression as well as the susceptibility of 2D-DIGE for methodological variations makes use of 2D-DIGE as a diagnostic tool for MS and for detection of possible candidate biomarkers difficult, since detected proteins vary depending on which samples are compared.

Indexed as

2D-DIGEdiagnosiselectrophoresismultiple sclerosisprotein

Identifiers

PMID29976874
PMCPMC6164878
OpenAlexW2810541129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.